Association Between Claims‐Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND‐DAPT Study
暂无分享,去创建一个
Neel M. Butala | J. Curtis | R. Yeh | Yang Song | J. Strom | K. Faridi | H. Kundi | Eric A. Secemsky | H. Tamez | Qi Gao | Changyu Shen | Luke Zheng | Hector Tamez
[1] D. Forman,et al. Interventions for Frailty Among Older Adults With Cardiovascular Disease: JACC State-of-the-Art Review. , 2022, Journal of the American College of Cardiology.
[2] J. Spertus,et al. Role of Frailty in Identifying Benefit From Transcatheter Versus Surgical Aortic Valve Replacement , 2021, Circulation. Cardiovascular quality and outcomes.
[3] Neel M. Butala,et al. Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings From the EXTEND-DAPT Study , 2021, Circulation.
[4] L. Barbieri,et al. In-hospital outcomes in nonagenarian patients undergoing primary percutaneous coronary intervention. , 2021, Minerva cardiology and angiology.
[5] J. Spertus,et al. Identification of Frailty Using a Claims‐Based Frailty Index in the CoreValve Studies: Findings from the EXTEND‐FRAILTY Study , 2021, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.
[6] Neel M. Butala,et al. Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study: Findings From the EXTEND-DAPT Study. , 2021, Circulation. Cardiovascular quality and outcomes.
[7] Neel M. Butala,et al. Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study. , 2020, Circulation.
[8] W. Weintraub,et al. Evaluating Clinical Outcomes From Administrative Databases. , 2020, JACC. Cardiovascular interventions.
[9] Neel M. Butala,et al. Validation of Administrative Claims to Ascertain Outcomes in Pivotal Trials of Transcatheter Aortic Valve Replacement. , 2020, JACC. Cardiovascular interventions.
[10] Neel M. Butala,et al. Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement , 2020, Circulation.
[11] A. Amanullah,et al. Association of frailty with all-cause mortality and bleeding among elderly patients with acute myocardial infarction: a systematic review and meta-analysis , 2020, Journal of geriatric cardiology : JGC.
[12] H. Koiwaya,et al. Impact of frailty on outcomes in elderly patients with acute myocardial infarction who undergo percutaneous coronary intervention. , 2020, European heart journal. Quality of care & clinical outcomes.
[13] R. Yeh,et al. Association of Frailty With 30-Day Outcomes for Acute Myocardial Infarction, Heart Failure, and Pneumonia Among Elderly Adults. , 2019, JAMA cardiology.
[14] J. Curtis,et al. Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study. , 2019, American heart journal.
[15] R. Yeh,et al. Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort. , 2019, European heart journal.
[16] M. Roe,et al. Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health , 2019, Clinical trials.
[17] R. Yeh,et al. The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip Procedure. , 2018, The Canadian journal of cardiology.
[18] M. Gulati,et al. The Association of Frailty With In-Hospital Bleeding Among Older Adults With Acute Myocardial Infarction: Insights From the ACTION Registry. , 2018, JACC. Cardiovascular interventions.
[19] R. Yeh,et al. Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare Beneficiaries , 2018, Circulation. Cardiovascular quality and outcomes.
[20] K. Alexander,et al. Frailty and Outcomes After Myocardial Infarction: Insights From the CONCORDANCE Registry , 2018, Journal of the American Heart Association.
[21] J. Avorn,et al. Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study. , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.
[22] Kenneth Rockwood,et al. Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.
[23] J. Zamorano,et al. The Role of Frailty in Acute Coronary Syndromes in the Elderly , 2018, Gerontology.
[24] A. Street,et al. Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study , 2018, The Lancet.
[25] G. Stone,et al. Short-Term Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Elderly Patients: A Meta-Analysis of Individual Participant Data From 6 Randomized Trials. , 2018, JACC. Cardiovascular interventions.
[26] C. Gale,et al. Frailty and acute coronary syndrome: A structured literature review , 2018, European heart journal. Acute cardiovascular care.
[27] S. Wong,et al. Frailty and Mortality Outcomes After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. , 2017, Journal of the American Medical Directors Association.
[28] R. Varadhan,et al. EXTERNAL VALIDATION OF THE CLAIMS-BASED FRAILTY INDEX IN THE NATIONAL HEALTH AND AGING TRENDS STUDY COHORT , 2017, American journal of epidemiology.
[29] R. Varadhan,et al. Development of a Claims-based Frailty Indicator Anchored to a Well-established Frailty Phenotype , 2017, Medical care.
[30] J. Z. Zamorano Gómez,et al. Frailty predicts major bleeding within 30days in elderly patients with Acute Coronary Syndrome. , 2016, International journal of cardiology.
[31] J. Spertus,et al. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. , 2016, JAMA.
[32] Mark McClellan,et al. The 21st Century Cures Act. , 2015, The New England journal of medicine.
[33] Peter L Duffy,et al. Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention. , 2015, Journal of the American College of Cardiology.
[34] Braunwald,et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. , 2014, The New England journal of medicine.
[35] B. Gersh,et al. Do current clinical trials meet society's needs?: a critical review of recent evidence. , 2014, Journal of the American College of Cardiology.
[36] Daniel E Forman,et al. Frailty assessment in the cardiovascular care of older adults. , 2014, Journal of the American College of Cardiology.
[37] David Erlinge,et al. Thrombus aspiration during ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.
[38] Adrian F Hernandez,et al. Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. , 2012, JAMA.
[39] K. Anstrom,et al. Linking the National Cardiovascular Data Registry CathPCI Registry With Medicare Claims Data: Validation of a Longitudinal Cohort of Elderly Patients Undergoing Cardiac Catheterization , 2012, Circulation. Cardiovascular quality and outcomes.
[40] NiklasEkerstad,et al. Frailty Is Independently Associated With Short-Term Outcomes for Elderly Patients With Non–ST-Segment Elevation Myocardial Infarction , 2011 .
[41] J. Spertus,et al. Influence of Frailty and Health Status on Outcomes in Patients With Coronary Disease Undergoing Percutaneous Revascularization , 2011, Circulation. Cardiovascular quality and outcomes.
[42] E. Peterson,et al. Percutaneous coronary intervention in the elderly , 2011, Nature Reviews Cardiology.
[43] Deepak L. Bhatt,et al. Bleeding Complications With Dual Antiplatelet Therapy Among Patients With Stable Vascular Disease or Risk Factors for Vascular Disease: Results From the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) Trial , 2010, Circulation.
[44] S. Pocock,et al. A risk score to predict bleeding in patients with acute coronary syndromes. , 2010, Journal of the American College of Cardiology.
[45] Fabian Nietlispach,et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. , 2010, Journal of the American College of Cardiology.
[46] S. Normand,et al. Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. , 2009, JAMA.
[47] Luigi Ferrucci,et al. Frailty: an emerging research and clinical paradigm--issues and controversies. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[48] I. McDowell,et al. A global clinical measure of fitness and frailty in elderly people , 2005, Canadian Medical Association Journal.
[49] Therese A. Stukel,et al. Long-term Outcomes of Regional Variations in Intensity of Invasive vs Medical Management of Medicare Patients With Acute Myocardial Infarction , 2005 .
[50] L. Fried,et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. , 2002, Archives of internal medicine.
[51] Emily K. Snell,et al. The 2030 problem: caring for aging baby boomers. , 2002, Health services research.
[52] L. Fried,et al. Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[53] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[54] J. Slaets,et al. Inclusion of frail elderly patients in clinical trials: solutions to the problems. , 2013, Journal of geriatric oncology.
[55] Satoshi Morita,et al. Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction. , 2013, Journal of the American College of Cardiology.
[56] P. Mody,et al. Frailty Is Independently Associated With Short-Term Outcomes for Elderly Patients With Non – ST-Segment Elevation – Myocardial Infarction , 2012 .
[57] Frans Van de Werf,et al. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.